Dian Diagnostics Group Co.,Ltd. (SHE:300244)
China · Delayed Price · Currency is CNY 19.08
+0.42 (2.25%)
May 19, 2026, 10:35 AM CST
Dian Diagnostics Group Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 129.43 | 44.05 | -357.28 | 307.46 | 1,434 | 1,163 |
Depreciation & Amortization | 442.62 | 442.62 | 609.44 | 691.44 | 799.5 | 494.73 |
Other Amortization | 131.33 | 131.33 | 116.36 | 100.53 | 89.14 | 75.17 |
Loss (Gain) From Sale of Assets | 0.18 | 0.18 | 1.48 | 3.57 | 11.18 | -6.35 |
Asset Writedown & Restructuring Costs | 99.58 | 99.58 | 391.11 | 25.72 | 831.79 | 21.53 |
Loss (Gain) From Sale of Investments | -29.72 | -29.72 | -9.99 | 18.32 | 7.45 | 124.89 |
Provision & Write-off of Bad Debts | 196.1 | 196.1 | 444.55 | 375.75 | 298.49 | 91.32 |
Other Operating Activities | 240.57 | 320.47 | 435.25 | 548.8 | 744.02 | 553.48 |
Change in Accounts Receivable | 1,277 | 1,277 | 139.29 | 1,969 | -4,152 | -2,030 |
Change in Inventory | 71.51 | 71.51 | -139.6 | 55.57 | -90.93 | -223.04 |
Change in Accounts Payable | -436.75 | -436.75 | -289.66 | -2,065 | 1,524 | 1,025 |
Change in Other Net Operating Assets | - | - | -3.92 | 13.84 | 58.6 | 121.93 |
Operating Cash Flow | 2,034 | 2,028 | 1,207 | 1,921 | 1,639 | 1,318 |
Operating Cash Flow Growth | 55.83% | 67.99% | -37.16% | 17.20% | 24.39% | -14.82% |
Capital Expenditures | -250.18 | -285.32 | -363.19 | -701.77 | -947.72 | -589.5 |
Sale of Property, Plant & Equipment | 27.45 | 28.32 | 9.73 | 22.03 | 14.76 | 24.59 |
Cash Acquisitions | -0.15 | -0.15 | -16.98 | -60.93 | -64.59 | -41.5 |
Divestitures | 0.78 | 0.78 | 88.59 | -13.07 | 0.32 | 0.85 |
Investment in Securities | -145.03 | -75.85 | -256.29 | 57.45 | -159.75 | -4.5 |
Other Investing Activities | 5.61 | 6.65 | 2.9 | 9.55 | 84.56 | 73.84 |
Investing Cash Flow | -361.53 | -325.57 | -535.24 | -686.74 | -1,072 | -536.22 |
Long-Term Debt Issued | - | 1,464 | 1,912 | 2,074 | 6,032 | 4,997 |
Total Debt Issued | 1,402 | 1,464 | 1,912 | 2,074 | 6,032 | 4,997 |
Long-Term Debt Repaid | - | -2,415 | -2,635 | -4,366 | -4,661 | -5,095 |
Total Debt Repaid | -2,337 | -2,415 | -2,635 | -4,366 | -4,661 | -5,095 |
Net Debt Issued (Repaid) | -934.89 | -950.59 | -722.99 | -2,292 | 1,371 | -97.05 |
Issuance of Common Stock | - | - | - | - | 158.32 | - |
Repurchase of Common Stock | - | - | -199.57 | -40.96 | -9.03 | - |
Common Dividends Paid | -244.9 | -255.8 | -575.71 | -300.62 | -296.9 | -266.12 |
Other Financing Activities | -153.2 | -183.93 | -336.04 | 200.59 | 204.47 | 53.17 |
Financing Cash Flow | -1,333 | -1,390 | -1,834 | -2,433 | 1,428 | -309.99 |
Foreign Exchange Rate Adjustments | -6.96 | -4.4 | 2.32 | 1.2 | 6.88 | -3.73 |
Net Cash Flow | 332.34 | 308.05 | -1,160 | -1,197 | 2,002 | 467.97 |
Free Cash Flow | 1,784 | 1,743 | 844.2 | 1,220 | 691.64 | 728.42 |
Free Cash Flow Growth | 91.07% | 106.47% | -30.78% | 76.33% | -5.05% | -32.02% |
Free Cash Flow Margin | 17.88% | 17.26% | 6.92% | 9.10% | 3.41% | 5.57% |
Free Cash Flow Per Share | 2.92 | 2.85 | 1.37 | 1.95 | 1.11 | 1.17 |
Cash Income Tax Paid | 550.03 | 546.31 | 566.37 | 843.93 | 1,017 | 707.36 |
Levered Free Cash Flow | 1,654 | 1,558 | 878.06 | 587.88 | -251.96 | -461.53 |
Unlevered Free Cash Flow | 1,749 | 1,659 | 1,005 | 744.51 | -80.26 | -317.65 |
Change in Working Capital | 823.73 | 823.73 | -423.51 | -150.25 | -2,576 | -1,200 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.